We believe that five gene targets tested in four independent mouse models of HCC – i.e. CTNNB1/MYC, NRASG12V/shp53, DEN/PB, and WD and CCL4 – will provide the greatest chance of yielding an optimal chemoprevention strategy. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.